Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / MMJ International Holdings Sues CMS...
Regulatory litigation

MMJ International Holdings Sues CMS Over Cannabinoid Program

Analysis based on 8 articles · First reported Apr 11, 2026 · Last updated Apr 16, 2026

Sentiment
10
Attention
2
Articles
8
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The litigation could impact the regulatory landscape for cannabinoid-based pharmaceuticals in the United States, potentially affecting investment in companies like MMJ International Holdings that follow the FDA pathway. A halt to the United States===Centers for Medicare & Medicaid Services' BEI program would reinforce the traditional drug approval process.

Pharmaceuticals Healthcare Biotechnology
Event Summary

MMJ International Holdings has joined a federal lawsuit challenging the United States===Centers for Medicare & Medicaid Services' (CMS) Substance Access Beneficiary Engagement Incentive (BEI) program. The company, which develops FDA-authorized cannabinoid therapies for neurological diseases like Huntington's disease and Multiple Sclerosis, argues that the BEI program undermines the established FDA drug development pathway by creating a federally supported distribution channel for non-FDA-approved cannabinoid products. The lawsuit, originally filed by Smart Approaches to Marijuana, seeks a preliminary injunction to halt the BEI program, which allows healthcare organizations to furnish hemp-derived cannabinoid products to Medicare beneficiaries for symptom management. A federal court hearing is scheduled for May 1, 2026, in the United States===United States District Court for the District of Columbia to determine if CMS lawfully implemented the program and if it should be temporarily stopped.

Key Actions
95 MMJ International Holdings joined federal litigation United States===Centers for Medicare & Medicaid Services
90 United States===Centers for Medicare & Medicaid Services launched Substance Access Beneficiary Engagement Incentive program
80 Smart Approaches to Marijuana filed lawsuit United States===Centers for Medicare & Medicaid Services
75 MMJ International Holdings developing cannabinoid therapies
Entities Involved
priv
MMJ International Holdings
MMJ International Holdings has joined federal litigation challenging the United States===Centers for Medicare & Medicaid Services' BEI program. The company is developing FDA-authorized cannabinoid therapies and argues that the BEI program undermines the regulatory pathway for pharmaceutical cannabinoid medicines, potentially weakening investor confidence and clinical trial recruitment.
Importance 90 Sentiment 20
govactor
United States===Centers for Medicare & Medicaid Services
The United States===Centers for Medicare & Medicaid Services is being challenged in federal court over its Substance Access Beneficiary Engagement Incentive (BEI) program. Plaintiffs argue that CMS implemented the program without proper rulemaking and exceeded its authority, creating a federally supported pathway for non-FDA-approved cannabinoid products.
Importance 85 Sentiment -10
govactor
United States===Food and Drug Administration
The United States===Food and Drug Administration's drug development pathway for cannabinoid therapies is at the center of the litigation. MMJ International Holdings is advocating for the integrity of this pathway against the United States===Centers for Medicare & Medicaid Services' BEI program.
Importance 70 Sentiment 10
per
Duane Boise
Duane Boise, CEO of MMJ International Holdings, has publicly stated the company's position on the litigation, emphasizing the importance of evidence-based medicine and the FDA drug approval process for cannabinoid therapies.
Importance 60 Sentiment 10
govactor
United States===United States District Court for the District of Columbia
The United States===United States District Court for the District of Columbia is scheduled to hear arguments on May 1, 2026, regarding a preliminary injunction and stay of agency action concerning the United States===Centers for Medicare & Medicaid Services' BEI program.
Importance 50 Sentiment 0
ngo
Smart Approaches to Marijuana
Smart Approaches to Marijuana originally filed the lawsuit challenging the legality of the United States===Centers for Medicare & Medicaid Services' BEI program, arguing against its implementation without proper notice-and-comment rulemaking.
Importance 40 Sentiment 5
priv
MMJ BioPharma Labs, Inc.
MMJ BioPharma Labs, Inc. is a subsidiary of MMJ International Holdings and is involved in the integrated regulatory platform for cannabinoid therapeutics.
Importance 30 Sentiment 15
+ 1 more entities View on Dashboard
Relationships
Duane Boise related ↔ MMJ International Holdings
MMJ BioPharma Labs, Inc. related ↔ MMJ International Holdings
MMJ BioPharma Cultivation, Inc. related ↔ MMJ International Holdings
United States===Food and Drug Administration related ↔ MMJ International Holdings
MMJ International Holdings related ↔ United States===Centers for Medicare & Medicaid Services
United States===Centers for Medicare & Medicaid Services related ↔ United States===Food and Drug Administration
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.